메뉴 건너뛰기




Volumn 5, Issue 3, 2012, Pages 303-311

Novel approaches to the treatment of sickle cell disease: The potential of histone deacetylase inhibitors

Author keywords

epigenetics; fetal hemoglobin; histone deacetylase inhibitors; hydroxyurea; panobinostat; sickle cell disease; vorinostat

Indexed keywords

2,2 DIMETHYLBUTYRATE; 4 PHENYLBUTYRIC ACID; 6 (1,3 DIOXO 1H,3H BENZO[DE]ISOQUINOLIN 2 YL) N HYDROXYHEXANAMIDE; ANTIANEMIC AGENT; APICIDIN; ARGININE BUTYRIC ACID; AZACITIDINE; BETA GLOBIN; BUTYRIC ACID DERIVATIVE; ENTINOSTAT; GAMMA GLOBIN; HELMINTHOSPORIUM CARBONUM TOXIN; HEMOGLOBIN A; HEMOGLOBIN F; HEMOGLOBIN S; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HQK 1001; HYDROXYUREA; POMALIDOMIDE; RECOMBINANT ERYTHROPOIETIN; ROMIDEPSIN; SIRTUIN; TRAPOXIN; TRICHOSTATIN A; UNCLASSIFIED DRUG;

EID: 84863801973     PISSN: 17474086     EISSN: 17474094     Source Type: Journal    
DOI: 10.1586/ehm.12.20     Document Type: Review
Times cited : (12)

References (88)
  • 1
    • 84863799081 scopus 로고    scopus 로고
    • FIFTY-Ninth World Health Assembly. WHO, Geneva, Switzerland
    • Sickle Cell Anaemia: REPORT by Secretariat. In: FIFTY-Ninth World Health Assembly. WHO, Geneva, Switzerland, 1-3 (2006).
    • (2006) Report by Secretariat , pp. 1-3
    • Sickle Cell Anaemia1
  • 2
    • 74049150729 scopus 로고    scopus 로고
    • The number of people with sickle-cell disease in the United States: National and state estimates
    • Brousseau DC, Panepinto JA, Nimmer M, Hoffmann RG. The number of people with sickle-cell disease in the United States: National and state estimates. Am. J. Hematol. 85(1), 77-78 (2010).
    • (2010) Am. J. Hematol. , vol.85 , Issue.1 , pp. 77-78
    • Brousseau, D.C.1    Panepinto, J.A.2    Nimmer, M.3    Hoffmann, R.G.4
  • 3
    • 0028291736 scopus 로고
    • Mortality in sickle cell disease Life expectancy and risk factors for early death
    • Platt OS, Brambilla DJ, Rosse WF et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N. Engl. J. Med. 330(23), 1639-1644 (1994).
    • (1994) N. Engl. J. Med. , vol.330 , Issue.23 , pp. 1639-1644
    • Platt, O.S.1    Brambilla, D.J.2    Rosse, W.F.3
  • 4
    • 0030893396 scopus 로고    scopus 로고
    • Fetal hemoglobin in sickle cell anemia: Determinants of response to hydroxyurea multicenter study of hydroxyurea
    • Steinberg MH, Lu ZH, Barton FB, Terrin ML, Charache S, Dover GJ. Fetal hemoglobin in sickle cell anemia: Determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea. Blood 89(3), 1078-1088 (1997).
    • (1997) Blood , vol.89 , Issue.3 , pp. 1078-1088
    • Steinberg, M.H.1    Lu, Z.H.2    Barton, F.B.3    Terrin, M.L.4    Charache, S.5    Dover, G.J.6
  • 5
    • 0037414164 scopus 로고    scopus 로고
    • Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: Risks and benefits up to 9 years of treatment
    • Steinberg MH, Barton F, Castro O et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: Risks and benefits up to 9 years of treatment. JAMA 289(13), 1645-1651 (2003).
    • (2003) JAMA , vol.289 , Issue.13 , pp. 1645-1651
    • Steinberg, M.H.1    Barton, F.2    Castro, O.3
  • 6
    • 77953057530 scopus 로고    scopus 로고
    • The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up
    • Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up
    • Steinberg MH, McCarthy WF, Castro O et al.; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up. Am. J. Hematol. 85(6), 403-408 (2010).
    • (2010) Am. J. Hematol. , vol.85 , Issue.6 , pp. 403-408
    • Steinberg, M.H.1    McCarthy, W.F.2    Castro, O.3
  • 7
    • 77950622293 scopus 로고    scopus 로고
    • The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: Results of a 17-year, single-center trial (LaSHS)
    • Voskaridou E, Christoulas D, Bilalis A et al. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: Results of a 17-year, single-center trial (LaSHS). Blood 115(12), 2354-2363 (2010).
    • (2010) Blood , vol.115 , Issue.12 , pp. 2354-2363
    • Voskaridou, E.1    Christoulas, D.2    Bilalis, A.3
  • 8
    • 33644841363 scopus 로고    scopus 로고
    • Leukocyte adhesion and the pathophysiology of sickle cell disease
    • Okpala I. Leukocyte adhesion and the pathophysiology of sickle cell disease. Curr. Opin. Hematol. 13(1), 40-44 (2006).
    • (2006) Curr. Opin. Hematol. , vol.13 , Issue.1 , pp. 40-44
    • Okpala, I.1
  • 9
    • 34548821573 scopus 로고    scopus 로고
    • Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin
    • Villagra J, Shiva S, Hunter LA, Machado RF, Gladwin MT, Kato GJ. Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood 110(6), 2166-2172 (2007).
    • (2007) Blood , vol.110 , Issue.6 , pp. 2166-2172
    • Villagra, J.1    Shiva, S.2    Hunter, L.A.3    Machado, R.F.4    Gladwin, M.T.5    Kato, G.J.6
  • 10
    • 27244435213 scopus 로고    scopus 로고
    • Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality
    • Kato GJ, Martyr S, Blackwelder WC et al. Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality. Br. J. Haematol. 130(6), 943-953 (2005).
    • (2005) Br. J. Haematol. , vol.130 , Issue.6 , pp. 943-953
    • Kato, G.J.1    Martyr, S.2    Blackwelder, W.C.3
  • 11
    • 0000343671 scopus 로고
    • The significance of the paucity of sickle cells in newborn Negro infants
    • Watson J. The significance of the paucity of sickle cells in newborn Negro infants. Am. J. Med. Sci. 215(4), 419-423 (1948).
    • (1948) Am. J. Med. Sci. , vol.215 , Issue.4 , pp. 419-423
    • Watson, J.1
  • 12
    • 8544220926 scopus 로고
    • Hereditary persistence of fetal hemoglobin a family study
    • Herman EC Jr, Conley CL. Hereditary persistence of fetal hemoglobin. A family study. Am. J. Med. 29, 9-17 (1960).
    • (1960) Am. J. Med. , vol.29 , pp. 9-17
    • Herman Jr., E.C.1    Conley, C.L.2
  • 13
    • 0020626383 scopus 로고
    • HbF levels, longevity of homozygotes and clinical course of sickle cell anemia in Brazil
    • Hutz MH, Salzano FM, Adams J. HbF levels, longevity of homozygotes and clinical course of sickle cell anemia in Brazil. Am. J. Med. Genet. 14(4), 669-676 (1983).
    • (1983) Am. J. Med. Genet. , vol.14 , Issue.4 , pp. 669-676
    • Hutz, M.H.1    Salzano, F.M.2    Adams, J.3
  • 14
    • 0022346620 scopus 로고
    • Hematological observations on Arabian SS patients with a homozygosity or heterozygosity for a beta S chromosome with haplotype #31
    • Kutlar A, Hattori Y, Bakioglu I, Kutlar F, Kamel K, Huisman TH. Hematological observations on Arabian SS patients with a homozygosity or heterozygosity for a beta S chromosome with haplotype #31. Hemoglobin 9(6), 545-557 (1985).
    • (1985) Hemoglobin , vol.9 , Issue.6 , pp. 545-557
    • Kutlar, A.1    Hattori, Y.2    Bakioglu, I.3    Kutlar, F.4    Kamel, K.5    Huisman, T.H.6
  • 15
    • 0025770390 scopus 로고
    • Pain in sickle cell disease Rates and risk factors
    • Platt OS, Thorington BD, Brambilla DJ et al. Pain in sickle cell disease. Rates and risk factors. N. Engl. J. Med. 325(1), 11-16 (1991).
    • (1991) N. Engl. J. Med. , vol.325 , Issue.1 , pp. 11-16
    • Platt, O.S.1    Thorington, B.D.2    Brambilla, D.J.3
  • 16
    • 0014960605 scopus 로고
    • Hemoglobin interaction: Modification of solid phase composition in the sickling phenomenon
    • Bertles JF, Rabinowitz R, Döbler J. Hemoglobin interaction: Modification of solid phase composition in the sickling phenomenon. Science 169(3943), 375-377 (1970).
    • (1970) Science , vol.169 , Issue.3943 , pp. 375-377
    • Bertles, J.F.1    Rabinowitz, R.2    Döbler, J.3
  • 17
    • 0016794848 scopus 로고
    • Role of hybrid tetramer formation in gelation of haemoglobin S
    • Bookchin RM, Nagel RL, Balazs T. Role of hybrid tetramer formation in gelation of haemoglobin S. Nature 256(5519), 667-668 (1975).
    • (1975) Nature , vol.256 , Issue.5519 , pp. 667-668
    • Bookchin, R.M.1    Nagel, R.L.2    Balazs, T.3
  • 18
    • 0006936094 scopus 로고
    • Structural bases of the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S
    • Nagel RL, Bookchin RM, Johnson J et al. Structural bases of the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S. Proc. Natl Acad. Sci. USA 76(2), 670-672 (1979).
    • (1979) Proc. Natl Acad. Sci. USA , vol.76 , Issue.2 , pp. 670-672
    • Nagel, R.L.1    Bookchin, R.M.2    Johnson, J.3
  • 20
    • 0025821277 scopus 로고
    • Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia
    • Orringer EP, Blythe DS, Johnson AE, Phillips G Jr, Dover GJ, Parker JC. Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia. Blood 78(1), 212-216 (1991).
    • (1991) Blood , vol.78 , Issue.1 , pp. 212-216
    • Orringer, E.P.1    Blythe, D.S.2    Johnson, A.E.3    Phillips Jr., G.4    Dover, G.J.5    Parker, J.C.6
  • 21
    • 0028038985 scopus 로고
    • Hydroxyurea affects cell morphology, cation transport, and red blood cell adhesion in cultured vascular endothelial cells
    • Adragna NC, Fonseca P, Lauf PK. Hydroxyurea affects cell morphology, cation transport, and red blood cell adhesion in cultured vascular endothelial cells. Blood 83(2), 553-560 (1994).
    • (1994) Blood , vol.83 , Issue.2 , pp. 553-560
    • Adragna, N.C.1    Fonseca, P.2    Lauf, P.K.3
  • 24
    • 0026631318 scopus 로고
    • Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia
    • Charache S, Dover GJ, Moore RD et al. Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia. Blood 79(10), 2555-2565 (1992).
    • (1992) Blood , vol.79 , Issue.10 , pp. 2555-2565
    • Charache, S.1    Dover, G.J.2    Moore, R.D.3
  • 25
    • 0022354852 scopus 로고
    • Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea
    • Veith R, Galanello R, Papayannopoulou T, Stamatoyannopoulos G. Stimulation of F-cell production in patients with sickle-cell anemia treated with cytarabine or hydroxyurea. N. Engl. J. Med. 313(25), 1571-1575 (1985).
    • (1985) N. Engl. J. Med. , vol.313 , Issue.25 , pp. 1571-1575
    • Veith, R.1    Galanello, R.2    Papayannopoulou, T.3    Stamatoyannopoulos, G.4
  • 26
    • 0029025475 scopus 로고
    • Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
    • Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia
    • Charache S, Terrin ML, Moore RD et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N. Engl. J. Med. 332(20), 1317-1322 (1995).
    • (1995) N. Engl. J. Med. , vol.332 , Issue.20 , pp. 1317-1322
    • Charache, S.1    Terrin, M.L.2    Moore, R.D.3
  • 27
    • 0030464953 scopus 로고    scopus 로고
    • Hydroxyurea and sickle cell anemia Clinical utility of a myelosuppressive switching agent the multicenter study of hydroxyurea in sickle cell anemia
    • Charache S, Barton FB, Moore RD et al. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Medicine (Baltimore) 75(6), 300-326 (1996).
    • (1996) Medicine (Baltimore) , vol.75 , Issue.6 , pp. 300-326
    • Charache, S.1    Barton, F.B.2    Moore, R.D.3
  • 30
    • 0019960147 scopus 로고
    • Maintenance of fetal hemoglobin (HbF) elevations in the baboon by prolonged erythropoietic stress
    • DeSimone J, Biel M, Heller P. Maintenance of fetal hemoglobin (HbF) elevations in the baboon by prolonged erythropoietic stress. Blood 60(2), 519-523 (1982).
    • (1982) Blood , vol.60 , Issue.2 , pp. 519-523
    • DeSimone, J.1    Biel, M.2    Heller, P.3
  • 31
    • 0021806584 scopus 로고
    • Treatment of baboon with vinblastine: Insights into the mechanisms of pharmacologic stimulation of HbF in the adult
    • Veith R, Papayannopoulou T, Kurachi S, Stamatoyannopoulos G. Treatment of baboon with vinblastine: Insights into the mechanisms of pharmacologic stimulation of HbF in the adult. Blood 66(2), 456-459 (1985).
    • (1985) Blood , vol.66 , Issue.2 , pp. 456-459
    • Veith, R.1    Papayannopoulou, T.2    Kurachi, S.3    Stamatoyannopoulos, G.4
  • 32
    • 0038784381 scopus 로고    scopus 로고
    • HbF reactivation in sibling BFU-E colonies: Synergistic interaction of kit ligand with low-dose dexamethasone
    • Gabbianelli M, Testa U, Massa A et al. HbF reactivation in sibling BFU-E colonies: Synergistic interaction of kit ligand with low-dose dexamethasone. Blood 101(7), 2826-2832 (2003).
    • (2003) Blood , vol.101 , Issue.7 , pp. 2826-2832
    • Gabbianelli, M.1    Testa, U.2    Massa, A.3
  • 33
    • 0000206049 scopus 로고
    • 5-azacytidine stimulates fetal hemoglobin synthesis in anemic baboons
    • DeSimone J, Heller P, Hall L, Zwiers D. 5-azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Proc. Natl Acad. Sci. USA 79(14), 4428-4431 (1982).
    • (1982) Proc. Natl Acad. Sci. USA , vol.79 , Issue.14 , pp. 4428-4431
    • DeSimone, J.1    Heller, P.2    Hall, L.3    Zwiers, D.4
  • 34
    • 0004959517 scopus 로고
    • Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex
    • Charache S, Dover G, Smith K, Talbot CC Jr, Moyer M, Boyer S. Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex. Proc. Natl Acad. Sci. USA 80(15), 4842-4846 (1983).
    • (1983) Proc. Natl Acad. Sci. USA , vol.80 , Issue.15 , pp. 4842-4846
    • Charache, S.1    Dover, G.2    Smith, K.3    Talbot Jr., C.C.4    Moyer, M.5    Boyer, S.6
  • 35
    • 0034307656 scopus 로고    scopus 로고
    • 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia
    • Koshy M, Dorn L, Bressler L et al. 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia. Blood 96(7), 2379-2384 (2000).
    • (2000) Blood , vol.96 , Issue.7 , pp. 2379-2384
    • Koshy, M.1    Dorn, L.2    Bressler, L.3
  • 36
    • 0036625004 scopus 로고    scopus 로고
    • Maintenance of elevated fetal hemoglobin levels by decitabine during dose interval treatment of sickle cell anemia
    • DeSimone J, Koshy M, Dorn L et al. Maintenance of elevated fetal hemoglobin levels by decitabine during dose interval treatment of sickle cell anemia. Blood 99(11), 3905-3908 (2002).
    • (2002) Blood , vol.99 , Issue.11 , pp. 3905-3908
    • DeSimone, J.1    Koshy, M.2    Dorn, L.3
  • 37
    • 10744231450 scopus 로고    scopus 로고
    • Effects of 5-aza-2́-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease
    • Saunthararajah Y, Hillery CA, Lavelle D et al. Effects of 5-aza-2́-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease. Blood 102(12), 3865-3870 (2003).
    • (2003) Blood , vol.102 , Issue.12 , pp. 3865-3870
    • Saunthararajah, Y.1    Hillery, C.A.2    Lavelle, D.3
  • 38
    • 0024334257 scopus 로고
    • Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with HbSS and beta thalassemia
    • Perrine SP, Miller BA, Faller DV et al. Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with HbSS and beta thalassemia. Blood 74(1), 454-459 (1989).
    • (1989) Blood , vol.74 , Issue.1 , pp. 454-459
    • Perrine, S.P.1    Miller, B.A.2    Faller, D.V.3
  • 39
    • 0010308916 scopus 로고
    • Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching
    • Perrine SP, Rudolph A, Faller DV et al. Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching. Proc. Natl Acad. Sci. USA 85(22), 8540-8542 (1988).
    • (1988) Proc. Natl Acad. Sci. USA , vol.85 , Issue.22 , pp. 8540-8542
    • Perrine, S.P.1    Rudolph, A.2    Faller, D.V.3
  • 40
    • 0024466232 scopus 로고
    • On the induction of fetal hemoglobin by butyrates: In vivo and in vitro studies with sodium butyrate and comparison of combination treatments with 5-AzaC and AraC
    • Constantoulakis P, Knitter G, Stamatoyannopoulos G. On the induction of fetal hemoglobin by butyrates: In vivo and in vitro studies with sodium butyrate and comparison of combination treatments with 5-AzaC and AraC. Blood 74(6), 1963-1971 (1989).
    • (1989) Blood , vol.74 , Issue.6 , pp. 1963-1971
    • Constantoulakis, P.1    Knitter, G.2    Stamatoyannopoulos, G.3
  • 41
    • 0033560094 scopus 로고    scopus 로고
    • Induction of fetal hemoglobin in sickle cell disease
    • Bunn HF. Induction of fetal hemoglobin in sickle cell disease. Blood 93(6), 1787-1789 (1999).
    • (1999) Blood , vol.93 , Issue.6 , pp. 1787-1789
    • Bunn, H.F.1
  • 42
    • 0027078611 scopus 로고
    • A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders
    • Perrine SP, Ginder GD, Faller DV et al. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. N. Engl. J. Med. 328(2), 81-86 (1993).
    • (1993) N. Engl. J. Med. , vol.328 , Issue.2 , pp. 81-86
    • Perrine, S.P.1    Ginder, G.D.2    Faller, D.V.3
  • 43
    • 0028303870 scopus 로고
    • Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate
    • Dover GJ, Brusilow S, Charache S. Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate. Blood 84(1), 339-343 (1994).
    • (1994) Blood , vol.84 , Issue.1 , pp. 339-343
    • Dover, G.J.1    Brusilow, S.2    Charache, S.3
  • 44
    • 84863808643 scopus 로고    scopus 로고
    • A Phase 2 Clinical Study of HQK-1001 2,2-dimethylbutyrate, sodium salt), a fetal hemoglobin inducer, in patients with sickle cell disease
    • Kutlar A, Inati A, Taher AT et al. A Phase 2 Clinical Study of HQK-1001 (2,2-dimethylbutyrate, sodium salt), a fetal hemoglobin inducer, in patients with sickle cell disease. Blood, 118 (2011).
    • (2011) Blood , pp. 118
    • Kutlar, A.1    Inati, A.2    Taher, A.T.3
  • 46
  • 48
    • 79960974473 scopus 로고    scopus 로고
    • Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice
    • Meiler SE, Wade M, Kutlar F et al. Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice. Blood 118(4), 1109-1112 (2011).
    • (2011) Blood , vol.118 , Issue.4 , pp. 1109-1112
    • Meiler, S.E.1    Wade, M.2    Kutlar, F.3
  • 49
    • 65449160927 scopus 로고    scopus 로고
    • Inhibition of histone deacetylases: A pharmacological approach to the treatment of non-cancer disorders
    • Wiech NL, Fisher JF, Helquist P, Wiest O. Inhibition of histone deacetylases: A pharmacological approach to the treatment of non-cancer disorders. Curr. Top. Med. Chem. 9(3), 257-271 (2009).
    • (2009) Curr. Top. Med. Chem. , vol.9 , Issue.3 , pp. 257-271
    • Wiech, N.L.1    Fisher, J.F.2    Helquist, P.3    Wiest, O.4
  • 51
    • 1842578986 scopus 로고    scopus 로고
    • Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis
    • Gregoretti IV, Lee YM, Goodson HV. Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis. J. Mol. Biol. 338(1), 17-31 (2004).
    • (2004) J. Mol. Biol. , vol.338 , Issue.1 , pp. 17-31
    • Gregoretti, I.V.1    Lee, Y.M.2    Goodson, H.V.3
  • 52
    • 0037406061 scopus 로고    scopus 로고
    • Class II histone deacetylases: Versatile regulators
    • Verdin E, Dequiedt F, Kasler HG. Class II histone deacetylases: Versatile regulators. Trends Genet. 19(5), 286-293 (2003).
    • (2003) Trends Genet. , vol.19 , Issue.5 , pp. 286-293
    • Verdin, E.1    Dequiedt, F.2    Kasler, H.G.3
  • 53
    • 33646366933 scopus 로고    scopus 로고
    • Two catalytic domains are required for protein deacetylation
    • Zhang Y, Gilquin B, Khochbin S, Matthias P. Two catalytic domains are required for protein deacetylation. J. Biol. Chem. 281(5), 2401-2404 (2006).
    • (2006) J. Biol. Chem. , vol.281 , Issue.5 , pp. 2401-2404
    • Zhang, Y.1    Gilquin, B.2    Khochbin, S.3    Matthias, P.4
  • 55
    • 0017767153 scopus 로고
    • N-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells
    • Riggs MG, Whittaker RG, Neumann JR, Ingram VM. n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells. Nature 268(5619), 462-464 (1977).
    • (1977) Nature , vol.268 , Issue.5619 , pp. 462-464
    • Riggs, M.G.1    Whittaker, R.G.2    Neumann, J.R.3    Ingram, V.M.4
  • 56
    • 0017898940 scopus 로고
    • Suppression of histone deacetylation in vivo and in vitro by sodium butyrate
    • Boffa LC, Vidali G, Mann RS, Allfrey VG. Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. J. Biol. Chem. 253(10), 3364-3366 (1978).
    • (1978) J. Biol. Chem. , vol.253 , Issue.10 , pp. 3364-3366
    • Boffa, L.C.1    Vidali, G.2    Mann, R.S.3    Allfrey, V.G.4
  • 57
    • 0024996768 scopus 로고
    • Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A
    • Yoshida M, Kijima M, Akita M, Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265(28), 17174-17179 (1990).
    • (1990) J. Biol. Chem. , vol.265 , Issue.28 , pp. 17174-17179
    • Yoshida, M.1    Kijima, M.2    Akita, M.3    Beppu, T.4
  • 58
    • 34547864236 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors: Molecular mechanisms of action
    • Xu WS, Parmigiani RB, Marks PA. Histone deacetylase inhibitors: Molecular mechanisms of action. Oncogene 26(37), 5541-5552 (2007).
    • (2007) Oncogene , vol.26 , Issue.37 , pp. 5541-5552
    • Xu, W.S.1    Parmigiani, R.B.2    Marks, P.A.3
  • 59
    • 70349100446 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors: Current status and overview of recent clinical trials
    • Ma X, Ezzeldin HH, Diasio RB. Histone deacetylase inhibitors: Current status and overview of recent clinical trials. Drugs 69(14), 1911-1934 (2009).
    • (2009) Drugs , vol.69 , Issue.14 , pp. 1911-1934
    • Ma, X.1    Ezzeldin, H.H.2    Diasio, R.B.3
  • 60
    • 79952262759 scopus 로고    scopus 로고
    • Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
    • Wagner JM, Hackanson B, Lübbert M, Jung M. Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy. Clin. Epigenetics 1(3-4), 117-136 (2010).
    • (2010) Clin. Epigenetics , vol.1 , Issue.3-4 , pp. 117-136
    • Wagner, J.M.1    Hackanson, B.2    Lübbert, M.3    Jung, M.4
  • 61
    • 1442331948 scopus 로고    scopus 로고
    • Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line demonstrates a major influence on heat-shock proteins
    • Wright JM, Zeitlin PL, Cebotaru L, Guggino SE, Guggino WB. Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line demonstrates a major influence on heat-shock proteins. Physiol. Genomics 16(2), 204-211 (2004).
    • (2004) Physiol. Genomics , vol.16 , Issue.2 , pp. 204-211
    • Wright, J.M.1    Zeitlin, P.L.2    Cebotaru, L.3    Guggino, S.E.4    Guggino, W.B.5
  • 62
    • 20244364534 scopus 로고    scopus 로고
    • Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator
    • Gondcaille C, Depreter M, Fourcade S et al. Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator. J. Cell Biol. 169(1), 93-104 (2005).
    • (2005) J. Cell Biol. , vol.169 , Issue.1 , pp. 93-104
    • Gondcaille, C.1    Depreter, M.2    Fourcade, S.3
  • 63
    • 33749507982 scopus 로고    scopus 로고
    • Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors
    • Minetti GC, Colussi C, Adami R et al. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat. Med. 12(10), 1147-1150 (2006).
    • (2006) Nat. Med. , vol.12 , Issue.10 , pp. 1147-1150
    • Minetti, G.C.1    Colussi, C.2    Adami, R.3
  • 65
    • 77955463320 scopus 로고    scopus 로고
    • Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease
    • Bradner JE, Mak R, Tanguturi SK et al. Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease. Proc. Natl Acad. Sci. USA 107(28), 12617-12622 (2010).
    • (2010) Proc. Natl Acad. Sci. USA , vol.107 , Issue.28 , pp. 12617-12622
    • Bradner, J.E.1    Mak, R.2    Tanguturi, S.K.3
  • 67
    • 0030923438 scopus 로고    scopus 로고
    • Induction of gammaglobin by histone deacetylase inhibitors
    • McCaffrey PG, Newsome DA, Fibach E, Yoshida M, Su MS. Induction of gammaglobin by histone deacetylase inhibitors. Blood 90(5), 2075-2083 (1997).
    • (1997) Blood , vol.90 , Issue.5 , pp. 2075-2083
    • McCaffrey, P.G.1    Newsome, D.A.2    Fibach, E.3    Yoshida, M.4    Su, M.S.5
  • 68
    • 33845244613 scopus 로고    scopus 로고
    • Histone deacetylase inhibitor FK228 is a potent inducer of human fetal hemoglobin
    • Cao H, Stamatoyannopoulos G. Histone deacetylase inhibitor FK228 is a potent inducer of human fetal hemoglobin. Am. J. Hematol. 81(12), 981-983 (2006).
    • (2006) Am. J. Hematol. , vol.81 , Issue.12 , pp. 981-983
    • Cao, H.1    Stamatoyannopoulos, G.2
  • 69
    • 0942266022 scopus 로고    scopus 로고
    • Induction of human gamma globin gene expression by histone deacetylase inhibitors
    • Cao H, Stamatoyannopoulos G, Jung M. Induction of human gamma globin gene expression by histone deacetylase inhibitors. Blood 103(2), 701-709 (2004).
    • (2004) Blood , vol.103 , Issue.2 , pp. 701-709
    • Cao, H.1    Stamatoyannopoulos, G.2    Jung, M.3
  • 71
    • 33751166387 scopus 로고    scopus 로고
    • Short-chain fatty acids induce gammaglobin gene expression by displacement of a HDAC3-NCoR repressor complex
    • Mankidy R, Faller DV, Mabaera R et al. Short-chain fatty acids induce gammaglobin gene expression by displacement of a HDAC3-NCoR repressor complex. Blood 108(9), 3179-3186 (2006).
    • (2006) Blood , vol.108 , Issue.9 , pp. 3179-3186
    • Mankidy, R.1    Faller, D.V.2    Mabaera, R.3
  • 72
    • 78751537137 scopus 로고    scopus 로고
    • Histone deacetylase 9 activates gamma-globin gene expression in primary erythroid cells
    • Muralidhar SA, Ramakrishnan V, Kalra IS, Li W, Pace BS. Histone deacetylase 9 activates gamma-globin gene expression in primary erythroid cells. J. Biol. Chem. 286(3), 2343-2353 (2011).
    • (2011) J. Biol. Chem. , vol.286 , Issue.3 , pp. 2343-2353
    • Muralidhar, S.A.1    Ramakrishnan, V.2    Kalra, I.S.3    Li, W.4    Pace, B.S.5
  • 74
    • 34547856653 scopus 로고    scopus 로고
    • The human Mi-2/NuRD complex and gene regulation
    • Denslow SA, Wade PA. The human Mi-2/NuRD complex and gene regulation. Oncogene 26(37), 5433-5438 (2007).
    • (2007) Oncogene , vol.26 , Issue.37 , pp. 5433-5438
    • Denslow, S.A.1    Wade, P.A.2
  • 75
    • 50149117726 scopus 로고    scopus 로고
    • DNA polymorphisms at the BCL11A HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease
    • Lettre G, Sankaran VG, Bezerra MA et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc. Natl Acad. Sci. USA 105(33), 11869-11874 (2008).
    • (2008) Proc. Natl Acad. Sci. USA , vol.105 , Issue.33 , pp. 11869-11874
    • Lettre, G.1    Sankaran, V.G.2    Bezerra, M.A.3
  • 76
    • 40349092939 scopus 로고    scopus 로고
    • Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia
    • Uda M, Galanello R, Sanna S et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc. Natl Acad. Sci. USA 105(5), 1620-1625 (2008).
    • (2008) Proc. Natl Acad. Sci. USA , vol.105 , Issue.5 , pp. 1620-1625
    • Uda, M.1    Galanello, R.2    Sanna, S.3
  • 77
    • 57849083996 scopus 로고    scopus 로고
    • Human fetal hemoglobin expression is regulated by the developmental stagespecific repressor BCL11A
    • Sankaran VG, Menne TF, Xu J et al. Human fetal hemoglobin expression is regulated by the developmental stagespecific repressor BCL11A. Science 322(5909), 1839-1842 (2008).
    • (2008) Science , vol.322 , Issue.5909 , pp. 1839-1842
    • Sankaran, V.G.1    Menne, T.F.2    Xu, J.3
  • 78
    • 33644881627 scopus 로고    scopus 로고
    • Fetal hemoglobin induction by histone deacetylase inhibitors involves generation of reactive oxygen species
    • Hsiao CH, Li W, Lou TF, Baliga BS, Pace BS. Fetal hemoglobin induction by histone deacetylase inhibitors involves generation of reactive oxygen species. Exp. Hematol. 34(3), 264-273 (2006).
    • (2006) Exp. Hematol. , vol.34 , Issue.3 , pp. 264-273
    • Hsiao, C.H.1    Li, W.2    Lou, T.F.3    Baliga, B.S.4    Pace, B.S.5
  • 79
    • 19644367000 scopus 로고    scopus 로고
    • Activation and signaling of the p38 MAP kinase pathway
    • Zarubin T, Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15(1), 11-18 (2005).
    • (2005) Cell Res. , vol.15 , Issue.1 , pp. 11-18
    • Zarubin, T.1    Han, J.2
  • 80
    • 0028064768 scopus 로고
    • Increased fetal hemoglobin production in patients receiving valproic acid for epilepsy
    • Collins AF, Dover GJ, Luban NL. Increased fetal hemoglobin production in patients receiving valproic acid for epilepsy. Blood 84(5), 1690-1691 (1994).
    • (1994) Blood , vol.84 , Issue.5 , pp. 1690-1691
    • Collins, A.F.1    Dover, G.J.2    Luban, N.L.3
  • 81
    • 0030856601 scopus 로고    scopus 로고
    • Valproic acid and augmentation of fetal hemoglobin in individuals with and without sickle cell disease
    • Selby R, Nisbet-Brown E, Basran RK, Chang L, Olivieri NF. Valproic acid and augmentation of fetal hemoglobin in individuals with and without sickle cell disease. Blood 90(2), 891-893 (1997).
    • (1997) Blood , vol.90 , Issue.2 , pp. 891-893
    • Selby, R.1    Nisbet-Brown, E.2    Basran, R.K.3    Chang, L.4    Olivieri, N.F.5
  • 82
    • 0026710710 scopus 로고
    • Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate
    • Dover GJ, Brusilow S, Samid D. Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate. N. Engl. J. Med. 327(8), 569-570 (1992).
    • (1992) N. Engl. J. Med. , vol.327 , Issue.8 , pp. 569-570
    • Dover, G.J.1    Brusilow, S.2    Samid, D.3
  • 84
    • 0036527775 scopus 로고    scopus 로고
    • Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer
    • Johnstone RW. Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 1(4), 287-299 (2002).
    • (2002) Nat. Rev. Drug Discov. , vol.1 , Issue.4 , pp. 287-299
    • Johnstone, R.W.1
  • 85
    • 35548970109 scopus 로고    scopus 로고
    • Role of epigenetic modifications in normal globin gene regulation and butyrate-mediated induction of fetal hemoglobin
    • Fathallah H, Weinberg RS, Galperin Y, Sutton M, Atweh GF. Role of epigenetic modifications in normal globin gene regulation and butyrate-mediated induction of fetal hemoglobin. Blood 110(9), 3391-3397 (2007).
    • (2007) Blood , vol.110 , Issue.9 , pp. 3391-3397
    • Fathallah, H.1    Weinberg, R.S.2    Galperin, Y.3    Sutton, M.4    Atweh, G.F.5
  • 86
    • 77950930726 scopus 로고    scopus 로고
    • Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6
    • Xu J, Sankaran VG, Ni M et al. Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6. Genes Dev. 24(8), 783-798 (2010).
    • (2010) Genes. Dev. , vol.24 , Issue.8 , pp. 783-798
    • Xu, J.1    Sankaran, V.G.2    Ni, M.3
  • 87
    • 77956630402 scopus 로고    scopus 로고
    • KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching
    • Zhou D, Liu K, Sun CW, Pawlik KM, Townes TM. KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching. Nat. Genet. 42(9), 742-744 (2010).
    • (2010) Nat. Genet. , vol.42 , Issue.9 , pp. 742-744
    • Zhou, D.1    Liu, K.2    Sun, C.W.3    Pawlik, K.M.4    Townes, T.M.5
  • 88
    • 81555205756 scopus 로고    scopus 로고
    • Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing
    • Xu J, Peng C, Sankaran VG et al. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing. Science 334(6058), 993-996 (2011).
    • (2011) Science , vol.334 , Issue.6058 , pp. 993-996
    • Xu, J.1    Peng, C.2    Sankaran, V.G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.